Acetaminophen / caffeine / chlorpheniramine / hydrocodone / phenylephrine Pregnancy and Breastfeeding Warnings
Brand names: Hycomine Compound
Acetaminophen / caffeine / chlorpheniramine / hydrocodone / phenylephrine Pregnancy Warnings
Acetaminophen/caffeine/chlorpheniramine/hydrocodone/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Acetaminophen/caffeine/chlorpheniramine/hydrocodone/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.
Acetaminophen / caffeine / chlorpheniramine / hydrocodone / phenylephrine Breastfeeding Warnings
There are no data on the excretion of acetaminophen/caffeine/chlorpheniramine/hydrocodone/phenylephrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother
References for pregnancy information
- (2022) "Product Information. Hycomine Compound (APAP/caffeine/CPM/hydrocodone/PE)." Endo Laboratories LLC
References for breastfeeding information
- (2022) "Product Information. Hycomine Compound (APAP/caffeine/CPM/hydrocodone/PE)." Endo Laboratories LLC
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.